Cargando…

Transmission of Human Immunodeficiency Virus I Drug Resistance - a Case Report. What are the Clinical Implications?

The success of first-line antiretroviral therapy can be challenged by the acquisition of primary drug resistance. Here we report a case where baseline genotypic resistance testing detected resistance conferring nucleoside/nucleotide reverse transcriptase inhibitor (NRTI)-associated mutations, but no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anadol, E, Kaiser, R, Verheyen, J, Schülter, E, Emmelkamp, J, Schwarze-Zander, C, Kupfer, B, Wasmuth, JC, Rockstroh, JK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352013/ https://www.ncbi.nlm.nih.gov/pubmed/20562063 http://dx.doi.org/10.1186/2047-783X-15-5-225

Ejemplares similares

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
por: Anadol, Evrim, et al.
Publicado: (2018)

Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence
por: Vogel, M, et al.
Publicado: (2011)

Rabies post-exposure prophylaxis in Germany − What are the challenges?
por: Meyerhoff, P., et al.
Publicado: (2021)

microRNA‐200a: A stage‐dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients
por: Austermann, Christian, et al.
Publicado: (2017)

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?
por: Mohr, Raphael, et al.
Publicado: (2015)

Implementation of EACS vaccination recommendations among people living with HIV
por: Breitschwerdt, Sven, et al.
Publicado: (2022)

Moderate endurance training (marathon-training) – effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project
por: Schlabe, Stefan, et al.
Publicado: (2017)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohort
por: Steffens, B, et al.
Publicado: (2011)

Time on drug analysis based on real life data
por: Schülter, Eugen, et al.
Publicado: (2014)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis
por: Mohr, Raphael, et al.
Publicado: (2018)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021)

Impact of COVID‐19 on HIV late diagnosis in a specialized German centre
por: van Bremen, Kathrin, et al.
Publicado: (2022)

Orthotopic Liver Transplantation in Human-Immunodeficiency-Virus-Positive Patients in Germany
por: Anadol, E., et al.
Publicado: (2012)

Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the IL28B gene
por: Lutz, P, et al.
Publicado: (2011)

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network
por: Bukkems, Vera, et al.
Publicado: (2020)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
por: Dold, L., et al.
Publicado: (2020)

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA*
por: Grint, D, et al.
Publicado: (2013)

Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection
por: Jansen, Christian, et al.
Publicado: (2015)

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017)

SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)
por: van Bremen, Kathrin, et al.
Publicado: (2021)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
por: Dold, Leona, et al.
Publicado: (2019)

Depression and suicide: What an evidence‐based clinician should know
por: Emmelkamp, Paul M. G., et al.
Publicado: (2022)

Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?
por: Menting, T., et al.
Publicado: (2021)

What was the primary mode of smallpox transmission? Implications for biodefense
por: Milton, Donald K.
Publicado: (2012)

Human Immunodeficiency Virus gag and protease: partners in resistance
por: Fun, Axel, et al.
Publicado: (2012)

HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life
por: Wesselmann, Paul, et al.
Publicado: (2020)

What Is Hereditary Transmission?
por: Goss, J. J. M.
Publicado: (1856)

Cutaneous PAN and Common Variable Immunodeficiency: what causes what?
por: Pagnini, Ilaria, et al.
Publicado: (2011)

Mother-to-child transmission of human immunodeficiency virus in aten years period
por: Delicio, Adriane M, et al.
Publicado: (2011)

IMPLICATION OF FIVE AIDS RELATED GENES IN MOTHER-TO-CHILD TRANSMISSION AND ACQUISITION OF HUMAN IMMUNODEFICIENCY VIRUS 1 IN CAMEROON
por: Mekue, Linda Mouafo, et al.
Publicado: (2018)

Inhibitors of human immunodeficiency virus type I
por: Hazuda, Daria J
Publicado: (2006)

Common variable immunodeficiency disorders: What generalists should know
por: Jeevarathnum, A C, et al.
Publicado: (2021)

Virome in immunodeficiency: what we know currently
por: Wang, Hu, et al.
Publicado: (2023)

Feline immunodeficiency virus in puma: Estimation of force of infection reveals insights into transmission
por: Reynolds, Jennifer J. H., et al.
Publicado: (2019)

INFECTIOUS AGAMMAGLOBULINEMIA: TRANSMISSION OF IMMUNODEFICIENCY WITH GRAFTS OF AGAMMAGLOBULINEMIC CELLS
por: Blaese, R. Michael, et al.
Publicado: (1974)

Transmission of human immunodeficiency virus infection by renal transplantation
por: Mukhopadhyay, P., et al.
Publicado: (2012)

HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?
por: Rockstroh, Jürgen Kurt, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5e4vob8ci00hl8hp69e670la4l